Assessment of the quality of life in type 2 diabetes patients – a comparative study of WHOQOL-BREF and DQOL instruments
DOI:
https://doi.org/10.15584/ejcem.2024.4.21Keywords:
DQOL, quality of life, type 2 diabetes mellitus, WHOQOL-BREFAbstract
Introduction and aim. Type 2 diabetes mellitus (T2DM) is a prevalent health issue that significantly impacts the quality of life of patients. Evaluating quality of life in T2DM patients is crucial for understanding the broader effects of the disease and improving patient care. This study aims to evaluate and compare the effectiveness of the WHOQOL-BREF and DQOL instruments in measuring the quality of life of T2DM patients.
Material and methods. A descriptive quantitative study was conducted from March to June 2023 at Puskesmas Wanadadi 1 Banjarnegara. The sample consisted of 195 T2DM patients selected using purposive sampling based on the following inclusion criteria: diagnosed with T2DM for at least one year, aged 30-70 years, willing to participate, and able to complete the questionnaires. Data were collected using the WHOQOL-BREF and DQOL questionnaires and analyzed descriptively.
Results. The analysis revealed that the WHOQOL-BREF and DQOL instruments provided comprehensive insights into the quality of life of T2DM patients. The WHOQOL-BREF was particularly effective in assessing physical and environmental domains (p<0.05), while the DQOL was more sensitive to diabetes-specific concerns and psychological well-being (p<0.05).
Conclusion. Both the WHOQOL-BREF and DQOL are effective in evaluating the quality of life of T2DM patients, each offering unique strengths in different domains. The findings suggest that a combined use of these instruments could provide a more holistic understanding of the quality of life impacts in T2DM patients, guiding more targeted interventions to improve patient outcomes.
Downloads
References
Tamornpark R, Utsaha S, Apidechkul T, Panklang D, Yeemard F, Srichan P. Quality of life and factors associated with a good quality of life among diabetes mellitus patients in northern Thailand. Health Qual Life Outcomes. 2022;20(1):81. doi: 10.1186/s12955-022-01986-y
Dehvan F, Saeed DM, Dehkordi AH, Gheshlagh RG. Quality of life of Iranian patients with type 2 diabetes: A systematic review and meta-analysis. Nursing Practice Today. 2019;6(4):167-175. doi: 10.18502/npt.v6i4.1939
Fakhri M, Abdan M, Ramezanpour M, Dehkordi AH, Sarikhani D. Systematic Review and Meta-Analysis on Quality of Life in Diabetic Patients in Iran. International Journal of Preventive Medicine. 2021;12(1):41. doi: 10.4103/ijpvm.IJPVM_327_19
Yousaf MF, Aslam A, Aslam Z, Mukhtar F. Assessment of Quality of Life of Patients with Type-II Diabetes Mellitus. Annals of Punjab Medical College. 2023;17(2):168-173. doi: 10.29054/apmc/2023.1388
Jain V, Shivkumar S, Gupta O. Health-Related Quality of Life (Hr-Qol) in Patients with Type 2 Diabetes Mellitus. N Am J Med Sci. 2014;6(2):96-101. doi: 10.4103/1947-2714.127752
Anwar SA, Arsyad DS, Dwinata I, Ansar J, Rachmat M. Quality life of PROLANIS participants using WHOQOL BREF Indonesian version: A community in primary health care. Enfermería Clínica. 2020;30:213-217. doi: 10.1016/j.enfcli.2019.07.081
Chew BH. Medication adherence on quality of life among adults with type 2 diabetes mellitus: an exploratory analysis on the EDDMQoL study. Qual Life Res. 2015;24(11):2723-2731. doi: 10.1007/s11136-015-1006-7
Lin CY, Lee TY, Sun ZJ, Yang YC, Wu JS, Ou HT. Development of diabetes-specific quality of life module to be in conjunction with the World Health Organization quality of life scale brief version (WHOQOL-BREF). Health Qual Life Outcomes. 2017;15(1):167. doi: 10.1186/s12955-017-0744-3
Kolarić V, Rahelić V, Šakić Z. The Quality of Life of Caregivers of People with Type 2 Diabetes Estimated Using the WHOQOL-BREF Questionnaire. Diabetology. 2023;4(4):430-439. doi: 10.3390/diabetology4040037
Patel B, Oza B, Patel K, Malhotra S, Patel V. Health related quality of life in type-2 diabetic patients in Western India using World Health Organization Quality of Life – BREF and appraisal of diabetes scale. Int J Diabetes Dev Ctries. 2014;34(2):100-107. doi: 10.1007/s13410-013-0162-y
Woon LSC, Sidi HB, Ravindran A, et al. Depression, anxiety, and associated factors in patients with diabetes: evidence from the anxiety, depression, and personality traits in diabetes mellitus (ADAPT-DM) study. BMC Psychiatry. 2020;20(1):227. doi: 10.1186/s12888-020-02615-y
Sarir N, Kohistani TA, Arshad AR, Ali G, Khitab S. Quality of Life in Patients of Type 2 Diabetes Mellitus. Pakistan Armed Forces Medical Journal. 2022;72(SUPPL-2):S255-58. doi: 10.51253/pafmj.v72iSUPPL-2.3456
Cepeda Marte JL, Ruiz-Matuk C, Mota M, et al. Quality of life and metabolic control in type 2 diabetes mellitus diagnosed individuals. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(5):2827-2832. doi: 10.1016/j.dsx.2019.07.062
Puspasari S, Farera DR. Quality of Life Among Patients with Type 2 Diabetic Mellitus in Outpatient Department, General Public Hospital, West Java. KnE Life Sciences. 2021:897-906. doi: 10.18502/kls.v6i1.8767
Homady A, Albasheer O, Bajawi A, et al. Health-related Quality of Life among Type 2 Diabetes Patients in Southern Province of Saudi Arabia using WHOQOL-BREF: A Cross-section Study. Current Diabetes Reviews. 2023;19(7):55-64. doi: 10.2174/1573399819666221221160136
Reba K, Birhane BW, Gutema H. Validity and Reliability of the Amharic Version of the World Health Organization’s Quality of Life Questionnaire (WHOQOL-BREF) in Patients with Diagnosed Type 2 Diabetes in Felege Hiwot Referral Hospital, Ethiopia. Journal of Diabetes Research. 2019;2019:e3513159. doi: 10.1155/2019/3513159
Kumar S. G, Majumdar A, G. P. Quality of Life (QOL) and Its Associated Factors Using WHOQOL-BREF Among Elderly in Urban Puducherry, India. J Clin Diagn Res. 2014;8(1):54-57. doi: 10.7860/JCDR/2014/6996.3917
Sreedevi A, Cherkil S, Kuttikattu DS, Kamalamma L, Oldenburg B. Validation of WHOQOL-BREF in Malayalam and Determinants of Quality of Life Among People With Type 2 Diabetes in Kerala, India. Asia Pac J Public Health. 2016;28(1):62S-69S. doi: 10.1177/1010539515605888
Ababio GK, Bosomprah S, Olumide A, et al. Predictors of Quality of Life in Patients With Diabetes Mellitus in Two Tertiary Health Institutions in Ghana and Nigeria. Nigerian Postgraduate Medical Journal. 2017;24(1):48. doi: 10.4103/npmj.npmj_3_17
Ligda G, Ploubidis D, Foteli S, Kontou PI, Nikolaou C, Tentolouris N. Quality of life in subjects with type 2 diabetes mellitus with diabetic retinopathy: A case–control study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(2):947-952. doi: 10.1016/j.dsx.2018.12.012
Eren İ, Erdi Ö, Şahin M. The effect of depression on quality of life of patients with type II diabetes mellitus. Depression and Anxiety. 2008;25(2):98-106. doi: 10.1002/da.20288
Al-Taie N, Maftei D, Kautzky-Willer A, Krebs M, Stingl H. Assessing the quality of life among patients with diabetes in Austria and the correlation between glycemic control and the quality of life. Primary Care Diabetes. 2020;14(2):133-138. doi: 10.1016/j.pcd.2019.11.003
Yeole UL, Jiandani MP, Kunjir SR, Bhat SM. Quality of Life of Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study. Medical Journal of Dr DY Patil University. 2020;13(4):311. doi: 10.4103/mjdrdypu.mjdrdypu_353_19
Shamshirgaran SM, Ataei J, Iranparvar Alamdari M, Safaeian A, Aminisani N. Predictors of health-related quality of life among people with type II diabetes Mellitus in Ardabil, Northwest of Iran, 2014. Primary Care Diabetes. 2016;10(4):244-250. doi: 10.1016/j.pcd.2015.11.004
Enang O, Omoronyia O, Asibong U, Ayuk A, Nwafor K, Legogie A. A case-control study of pattern and determinants of quality of life of patients with diabetes in a developing country. J Egypt Public Health Assoc. 2021;96(1):2. doi: 10.1186/s42506-020-00061-y
Derakhshanpour F, Vakili MA, Farsinia M, Mirkarimi K. Depression and Quality of Life in Patients With Type 2 Diabetes. Iran Red Crescent Med J. 2015;17(5):e27676. doi: 10.5812/ircmj.17(5)2015.27676
Abbasi-Ghahramanloo A, Soltani-Kermanshahi M, Mansori K, et al. Comparison of SF-36 and WHOQoL-BREF in Measuring Quality of Life in Patients with Type 2 Diabetes. International Journal of General Medicine. 2020;13:497-506. doi: 10.2147/IJGM.S258953
Aschalew AY, Yitayal M, Minyihun A. Health-related quality of life and associated factors among patients with diabetes mellitus at the University of Gondar referral hospital. Health Qual Life Outcomes. 2020;18(1):62. doi: 10.1186/s12955-020-01311-5
Amin MF, Bhowmik B, Rouf R, et al. Assessment of quality of life and its determinants in type-2 diabetes patients using the WHOQOL-BREF instrument in Bangladesh. BMC Endocr Disord. 2022;22(1):162. doi: 10.1186/s12902-022-01072-w
Reba K, Argaw Z, Walle B, Gutema H. Health-related quality of life of patients with diagnosed type 2 diabetes in Felege Hiwot Referral Hospital, North West Ethiopia: a cross-sectional study. BMC Res Notes. 2018;11(1):544. doi: 10.1186/s13104-018-3625-x
Gholami A, Azini M, Borji A, Shirazi F, Sharafi Z, Zarei E. Quality of Life in Patients with Type 2 Diabetes: Application of WHOQoL-BREF Scale. Shiraz E-Med J. 2013;14(3):162-171.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
